Suppr超能文献

相似文献

1
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases.
Nature. 2013 Sep 5;501(7465):45-51. doi: 10.1038/nature12481.
2
Prions: generation and spread versus neurotoxicity.
J Biol Chem. 2014 Jul 18;289(29):19862-8. doi: 10.1074/jbc.R114.568477. Epub 2014 May 23.
3
Proteopathic Strains and the Heterogeneity of Neurodegenerative Diseases.
Annu Rev Genet. 2016 Nov 23;50:329-346. doi: 10.1146/annurev-genet-120215-034943.
4
Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
Biomolecules. 2021 Feb 2;11(2):207. doi: 10.3390/biom11020207.
5
Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.
Trends Biochem Sci. 2006 Mar;31(3):150-5. doi: 10.1016/j.tibs.2006.01.002. Epub 2006 Feb 13.
6
[The Propagation Hypothesis of Prion-like Protein Agregates in Neurodegenerative Diseases].
Brain Nerve. 2019 Nov;71(11):1209-1214. doi: 10.11477/mf.1416201430.
7
Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders.
Ann Neurol. 2011 Oct;70(4):532-40. doi: 10.1002/ana.22615.
9
[The role of proteins in neurodegenerative disease].
Postepy Hig Med Dosw (Online). 2012 Apr 16;66:187-95. doi: 10.5604/17322693.991446.
10
Mouse models for studying the formation and propagation of prions.
J Biol Chem. 2014 Jul 18;289(29):19841-9. doi: 10.1074/jbc.R114.550707. Epub 2014 May 23.

引用本文的文献

2
Arterial stiffness and vascular aging: mechanisms, prevention, and therapy.
Signal Transduct Target Ther. 2025 Sep 1;10(1):282. doi: 10.1038/s41392-025-02346-0.
3
Human Glucose Transporters in Health and Selected Neurodegenerative Diseases.
Int J Mol Sci. 2025 Jul 31;26(15):7392. doi: 10.3390/ijms26157392.
5
Personalised regional modelling predicts tau progression in the human brain.
PLoS Biol. 2025 Jul 21;23(7):e3003241. doi: 10.1371/journal.pbio.3003241. eCollection 2025 Jul.
6
Cerebrospinal fluid ubiquitin as a biomarker for neurodegenerative diseases: A systematic review.
Neurosci Appl. 2023 Oct 23;2:102438. doi: 10.1016/j.nsa.2023.102438. eCollection 2023.
7
A structure-guided antibody detects SOD1 oligomers in diverse ALS genotypes.
bioRxiv. 2025 May 8:2025.05.05.652290. doi: 10.1101/2025.05.05.652290.

本文引用的文献

1
Seeded strain-like transmission of β-amyloid morphotypes in APP transgenic mice.
EMBO Rep. 2013 Nov;14(11):1017-22. doi: 10.1038/embor.2013.137. Epub 2013 Sep 3.
2
Distinct α-synuclein strains differentially promote tau inclusions in neurons.
Cell. 2013 Jul 3;154(1):103-17. doi: 10.1016/j.cell.2013.05.057.
3
Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum.
Trends Neurosci. 2013 Aug;36(8):450-9. doi: 10.1016/j.tins.2013.04.010. Epub 2013 Jun 7.
4
Brain homogenates from human tauopathies induce tau inclusions in mouse brain.
Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9535-40. doi: 10.1073/pnas.1301175110. Epub 2013 May 20.
5
Stages of pTDP-43 pathology in amyotrophic lateral sclerosis.
Ann Neurol. 2013 Jul;74(1):20-38. doi: 10.1002/ana.23937. Epub 2013 Jun 19.
6
Stress granules as crucibles of ALS pathogenesis.
J Cell Biol. 2013 Apr 29;201(3):361-72. doi: 10.1083/jcb.201302044.
7
Spike bursts increase amyloid-β 40/42 ratio by inducing a presenilin-1 conformational change.
Nat Neurosci. 2013 May;16(5):587-95. doi: 10.1038/nn.3376. Epub 2013 Apr 7.
8
Intrinsic connectivity network disruption in progressive supranuclear palsy.
Ann Neurol. 2013 May;73(5):603-16. doi: 10.1002/ana.23844. Epub 2013 Mar 27.
9
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
Lancet Neurol. 2013 Apr;12(4):357-67. doi: 10.1016/S1474-4422(13)70044-9. Epub 2013 Mar 8.
10
Prion-like spreading of pathological α-synuclein in brain.
Brain. 2013 Apr;136(Pt 4):1128-38. doi: 10.1093/brain/awt037. Epub 2013 Mar 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验